Related Experiment Video

Updated: Jul 4, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

[Update on the etiology and pathogenesis of multiple sclerosis and neuromyelitis optica]

Kazuo Fujihara1

  • 1Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 11, 2008
PubMed

Insights

New insights into multiple sclerosis (MS) and neuromyelitis optica (NMO) reveal genetic and environmental factors in MS, alongside distinct pathogenic mechanisms and therapeutic targets for both conditions.

Area of Science:

  • Neuroimmunology
  • Genetics
  • Pathology

Context:

  • Review of recent findings on the etiology and pathogenesis of multiple sclerosis (MS) and neuromyelitis optica (NMO).
  • Identification of new MS-susceptibility genes, including IL-7Ralpha and IL-2Ralpha.
  • Exploration of environmental factors such as Epstein-Barr virus, vitamin D, and smoking in MS development.

Purpose:

  • To synthesize recent advancements in understanding MS and NMO.
  • To highlight novel genetic and environmental contributors to MS.
  • To differentiate pathological mechanisms and therapeutic strategies for MS and NMO.

Summary:

  • New MS susceptibility genes (IL-7Ralpha, IL-2Ralpha) and environmental factors (Epstein-Barr virus, vitamin D, smoking) have been identified.
  • Antibody- and complement-mediated myelin phagocytosis is now recognized as the dominant demyelination mechanism in MS.
  • Monoclonal antibody therapies targeting immune molecules (CD52, CD25, VLA-4, CD20) show therapeutic effectiveness in MS.
  • Aquaporin-4 (AQP4) antibody serves as a biomarker for NMO, where severe astrocytic damage, distinct from MS, is observed.

Impact:

  • Advances understanding of MS and NMO pathogenesis.
  • Identifies potential targets for novel therapeutic interventions.
  • Provides a basis for improved diagnostics and treatment strategies for demyelinating diseases.

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...